RALEFLUX 20

RALEFLUX 20 is a highly effective gastroprotective medication containing Rabeprazole 20 mg, a proton pump inhibitor (PPI) designed to reduce excessive gastric acid production and provide relief from a range of acid-related gastrointestinal disorders. It is specifically formulated to manage conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, peptic ulcers, and Zollinger-Ellison syndrome.

Rabeprazole, the active ingredient in RALEFLUX 20, works by selectively blocking proton pumps in the stomach lining, which are responsible for secreting hydrochloric acid. By reducing acid production, it alleviates common symptoms such as heartburn, acidity, regurgitation, sour belching, and upper abdominal discomfort, while also promoting healing of the gastric and esophageal mucosa.

RALEFLUX 20 is recommended for patients suffering from chronic or recurrent acidity, GERD, NSAID-induced gastric irritation, or peptic ulcer disease. It is especially useful for individuals with lifestyle-induced acid problems caused by irregular meal timings, stress, spicy or oily food consumption, or prolonged use of medications that irritate the stomach. By controlling acid secretion effectively, the medicine helps prevent complications like erosions, ulcers, and esophagitis.

Regular use of RALEFLUX 20, under medical supervision, not only relieves acute symptoms but also supports long-term gastrointestinal health. Patients often experience improved digestion, reduced bloating, enhanced appetite, and better nutrient absorption. Its rapid onset of action provides quick relief from discomfort, while sustained acid suppression promotes complete healing of the stomach and esophagus.

Well-tolerated and safe when taken as prescribed, RALEFLUX 20 is an ideal solution for both acute and chronic acid-related disorders. With its effective acid suppression, mucosal protection, and fast symptom relief, RALEFLUX 20 ensures lasting digestive comfort and supports overall gastrointestinal wellness.